本文へ
MMadical AI Use
ベンダー報告ニュース

Worklist triage for critical findings on chest radiographs

この言語の本文は未訳のため、英語で表示しています。

Several cleared products flag possible urgent findings on a chest radiograph, such as pneumothorax, and move that study up a reading worklist. Names often cited for this job include Lunit INSIGHT CXR, Annalise Enterprise CXR, and qXR. This card describes the shared workflow, not a head-to-head, and it does not pool accuracy numbers across vendors. A flagged study still needs a radiologist’s report.

臨床の場

Emergency departments, inpatient wards, and outpatient imaging lists where a portable or departmental chest radiograph is acquired before a radiologist’s formal read.

ツールとベンダー

  • Lunit INSIGHT CXR
  • Annalise Enterprise CXR
  • qXR (Qure.ai)

出典が報告したこと

No pooled performance figure. Each product’s labeled use and published accuracy differ; check the specific clearance rather than a category average.

出典

U.S. FDA AI/ML-enabled device list · 2024年5月1日 · 年 2024

索引への追加 2026年10月4日

出典を開く

タグ

  • ワークリスト
  • コンピュータビジョン
  • 規制

教育と市場把握のための条目。医療助言でも推奨でもありません。

関連シナリオ

この領域のすべて

画像と放射線

規制

Autonomous diabetic retinopathy screening in primary care

IDx-DR, now marketed as LumineticsCore by Digital Diagnostics, was authorized to screen adults with diabetes for more-than-mild diabetic retinopathy without an eye specialist reading the photo first. A primary care team captures images on a specified retinal camera and the software returns a refer-or-rescreen result. It is not a complete eye examination. Pregnancy and several existing retinal conditions sit outside the labeled use.

LumineticsCore (IDx-DR) · Digital Diagnostics · Topcon NW400

ニュース · 2018事例を読む

画像と放射線

論文

AI-supported reading in the MASAI mammography trial

The MASAI trial in Sweden randomly assigned screening mammograms to AI-supported reading or standard double reading without AI. Transpara scored each exam and routed lower scores to a single reader and the highest score to double reading, with detection marks available on higher-risk exams. This card quotes the prespecified interim safety analysis, not a claim that every screening program should switch.

Transpara 1.7.0 · ScreenPoint Medical

論文 · 2023事例を読む

トリアージと救急

規制

Parallel notification of a suspected large-vessel occlusion

Viz.ai ContaCT analyzes brain CT angiography and can text a neurovascular specialist when it suspects a large-vessel occlusion, in parallel with the usual read. FDA permitted marketing in 2018 as notification software. The specialist still reviews full images on a diagnostic workstation. The product is not a diagnosis and not a treatment decision.

Viz.ai ContaCT

ニュース · 2018事例を読む
スポンサー

このインデックスの臨床読者に届ける。

スポンサー枠を見る